What are the Challenges in Targeting TNF-α for Cancer Treatment?
The main challenge is the dual role of TNF-α. Inhibiting TNF-α can impair the immune system's ability to fight infections and may also reduce the anti-tumor immune response. Additionally, chronic inhibition of TNF-α can lead to adverse effects such as increased risk of infections and autoimmune diseases.
